Briefing
Earlier is not necessarily actionable: the clinical dilemma of circulating tumor DNA-detected molecular relapse in resected melanoma
This short commentary (pages 592-593) discusses the clinical dilemma of acting on ctDNA-detected molecular relapse after resection of melanoma. No abstract was available, so no further findings are summarized here.
- Design: Evidence level 3
- Assay: Not named in the abstract
Melanoma ResearchPubMed 42956181DOI 10.1097/CMR.0000000000001146